Physician profile
Benedict P Ancock
NPI 1578847844
$3,666.07
in general payments reported to CMS, 2019-2025
17 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $1,482 · 2021: $84.22 · 2022: $300 · 2023: $43.37 · 2024: $1,138 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $690 · Food and Beverage: $598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $689.65 |
| Food and Beverage | $598.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,838.57 | 2019-2025 | Mitraclip, Pressurewire |
| Edwards Lifesciences Corporation | $733.15 | 2024 | Pascal |
| Heartflow, INC. | $332.70 | 2019-2024 | |
| Boston Scientific Corporation | $291.27 | 2019-2025 | Watchman Flx |
| Mirum Pharmaceuticals, INC. | $150.75 | 2024 | Livmarli |
| Janssen Pharmaceuticals, INC | $62.87 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.06 | 2019-2022 | |
| Cardiva Medical, INC. | $29.18 | 2024-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Bardy Diagnostics, INC. | $28.43 | 2022 | |
| Teleflex LLC | $28.15 | 2023 | Manta |
| Lantheus Medical Imaging, INC. | $26.49 | 2020 | |
| Sanofi-Aventis U.S. LLC | $22.10 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $21.02 | 2019 | |
| Amgen INC. | $20.94 | 2019 | |
| Pfizer INC. | $16.35 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $14.75 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benedict Ancock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.